Revolution Medicines Officer Stephen Kelsey Files Form 144 for $18.8M Proposed Sale
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Filing Alert: Revolution Medicines, Inc. (RVMD) • Insider: Stephen Kelsey (Officer) • Proposed Sale: 92,531 shares ($18,816,178.85 est. value) • Approx. Sale Date: September 11, 2026 • Plan Adoption Date: June 12, 2026 (Rule 10b5-1) • Broker: Morgan Stanley Smith Barney LLC
Comprehensive Analysis
Executive Summary
On September 11, 2026, Stephen Kelsey, an Officer of Revolution Medicines, Inc. (CIK: 0001628171), filed Form 144 with the SEC indicating a notice of proposed sale of 92,531 shares of Common Stock with an estimated aggregate market value of $18,816,178.85 (~$203.35/share).
Key Transaction Highlights
- Securities to be Sold: 92,531 Common Shares
- Aggregate Market Value: $18,816,178.85
- Acquisition Source: Stock Option Exercise (Cash payment to Issuer)
- Rule 10b5-1 Plan Adoption: Adopted on June 12, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Prior Sales: 4,175 shares sold on June 16, 2026, for gross proceeds of $651,797.66
Context and Analysis
The proposed transaction represents a significant dollar-value sale ($18.8M+), executed pursuant to a pre-arranged Rule 10b5-1 trading plan established on June 12, 2026. The shares represent a small fraction relative to the 214,336,418 total common shares outstanding.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.